Urinalysis Market Overview and Introduction

The global urinalysis market is estimated to be over US$ 1.4 Bn in 2017. It is anticipated to grow at a CAGR of 6.3% from 2019 to 2030. The global market is segmented by product type, test type, application, end user and region.

Urinalysis refers to clinical tests which are performed on the urine. Such tests assists in detecting and managing a broad range of disorders, namely kidney disease, urinary tract infections, and diabetes among others. The process of analysis involves examination of multiple parameters of the urine such as concentration, appearance and content. An abnormal result in urinal urinalysis tests indicates an illness or disease.

The global urinalysis market is driven by increasing incidences and prevalence of urinary tract infections (UTI) or other form of kidney disorders coupled with increasing geriatric population. Technological advancements, health care expenditure and availability of favorable government regulations are major factors driving the market. However, lack of infrastructural qualification among developing nations is likely to restrain the market to certain extent.

Urinalysis Market by Product Type

On the basis of product type, the urinalysis market is segmented into instruments and consumables. The segment of consumables is anticipated to account for the highest market share in 2018, owing to recurring purchase costs associated with disposable consumables.

Urinalysis Market by Test Type

The test type segment can be segmented into sediment urinalysis, and biochemical urinalysis. Biochemical urinalysis segment is anticipated to be the major revenue generating segment, owing to adoption of new innovative technologies to improve the overall efficiency of several tests.

Urinalysis Market by Application

On the basis of application, the market can be segmented into pregnancy tests and disease diagnostics. The segment of disease diagnostics is estimated to account for the largest share of the global urinalysis market. The large share of this segment can be attributed to development of novel tests and analysis studies for early diagnosis of several types of chronic diseases.

Urinalysis Market by End User

Finally, on the basis of end user, the urinalysis market is segmented into hospitals and clinical laboratories, research laboratories and institutes, diagnostics laboratories and home care settings. The hospitals and clinical laboratories segment is estimated to account for the largest share of the urinalysis market. Increasing incidences and prevalence of chronic diseases and the improving healthcare infrastructure are some of the factors driving the growth of end-user segment.

Urinalysis Market by Regions

The global urinalysis market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of urinalysis, followed by Europe and Asia Pacific. North America will continue to dominate the global urinalysis market in the forecast period owing to factors such as increasing prevalence of kidney disorders and highly developed healthcare system. However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan. Factors such as the rising focus of major players in emerging Asian countries, improving healthcare systems and government support are driving the growth of the urinalysis market in this region.

Urinalysis Market Prominent Players

The prominent players in the global urinalysis market are Siemens Healthcare Private Limited, Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.), Beckman Coulter, Inc., Sysmex Corporation, ARKRAY, Inc., ACON Laboratories, Inc., Bio-Rad Laboratories, Inc., Elektronika Kft., Mindray Medical International Limited (Shenzhen Mindray Bio-Medical Electronics Co.,), and URIT Medical among others